A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
View Top Employees from EchosensWebsite | http://www.echosens.com |
Revenue | $62.7 million |
Employees | 275 (274 on RocketReach) |
Founded | 2001 |
Address | 6 rue Ferrus, Paris, Île-de-France 75014, FR |
Phone | +33 1 44 82 78 50 |
Technologies |
JavaScript,
HTML,
PHP
+41 more
(view full list)
|
Category | Medical Devices, Vitamins, Supplements & Health Stores, Health Diagnostics, Diagnostic non-invasif en hépatologie, Retail, Health Care, Pionnier en Elastographie quantitative, Manufacturing, Evaluation de la fibrose hépatique et de la cirrhose, Medical Device |
Web Rank | 3 Million |
Keywords | echosense, ecosense fibrosis, echosens ipo hong kong, un fibroscan, "@endodiag.com" |
SIC | 30, 38, 384, 308 |
NAICS | 33, 339, 334 |
Looking for a particular Echosens employee's phone or email?
The Echosens annual revenue was $62.7 million in 2023.
Laurent Sandrin is the Chairman and Chief Technology Officer of Echosens.
274 people are employed at Echosens.
Echosens is based in Paris, Île-de-France.
The NAICS codes for Echosens are [33, 339, 334].
The SIC codes for Echosens are [30, 38, 384, 308].